b-cap
Showing 1 - 1 of 1
Hodgkin Lymphoma Trial in Cologne (B-CAP, Brentuximab Vedotin)
Active, not recruiting
- Hodgkin Lymphoma
- B-CAP
- Brentuximab Vedotin
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Aug 5, 2022